BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1280319)

  • 21. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
    Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostically relevant factors in papillary thyroid cancer].
    Böttger T; Klupp J; Gabbert HE; Junginger T
    Med Klin (Munich); 1991 Feb; 86(2):76-82. PubMed ID: 2030663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
    Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
    Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
    Hughes CJ; Shaha AR; Shah JP; Loree TR
    Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery for papillary thyroid carcinoma: is lobectomy enough?
    Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
    Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of surgical treatment results in patients with differentiated thyroid cancer from materials in the Oncologic Institute in Gliwice].
    Włoch J; Czarniecka A; Turska M; Wilgus J
    Wiad Lek; 2001; 54 Suppl 1():178-88. PubMed ID: 12182023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical treatment of differentiated carcinoma of the thyroid. Follow-up of 99 cases].
    Pozzetto B; Roseano M; Dellach C; Leggeri A
    Chir Ital; 2000; 52(1):49-56. PubMed ID: 10832526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral versus bilateral thyroid resection in differentiated thyroid carcinoma.
    Groot G; Colquhoun BP; Murphy FA
    Can J Surg; 1992 Oct; 35(5):517-20. PubMed ID: 1393868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some factors influencing the survival of patients with less advanced stages of differentiated thyroid cancer.
    Nĕmec J; Zamrazil V; Pohunkovå D; Röhling S; Zeman V
    Endocrinol Exp; 1986 Mar; 20(1):85-95. PubMed ID: 3486115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
    Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
    Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid.
    Van Nguyen K; Dilawari RA
    Am Surg; 1995 Feb; 61(2):151-5. PubMed ID: 7856976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.